Belmont Global Advisors’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Belmont Global Advisors’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$1.49M	Sell	270,000 -115,000	-30%	-$538K	1.41%	11
2016 Q2	$1.46M	Sell	385,000 -15,000	-4%	-$50.8K	1.4%	11
2016 Q1	$1.1M	Buy	400,000 +257,500	+181%	+$933K	1.12%	20
2015 Q4	$808K	Buy	142,500 +67,500	+90%	+$411K	1.05%	26
2015 Q3	$397K	Buy	75,000 +38,800	+107%	+$300K	0.67%	43
2015 Q2	$300K	Sell	36,200 -13,800	-28%	-$66.9K	0.33%	80
2015 Q1	$231K	Buy	+50,000	New	+$163K	0.23%	74
2014 Q4	–	Sell	-20,000	Closed	-$56K	–	147
2014 Q3	$56K	Sell	20,000 -198,000	-91%	-$718K	0.04%	119
2014 Q2	$887K	Sell	218,000 -32,000	-13%	-$136K	0.64%	47
2014 Q1	$1.33M	Sell	250,000 -3,500	-1%	-$19.6K	1.12%	23
2013 Q4	$1.41M	Buy	+253,500	New	+$1.09M	1.14%	24

Other funds holding SGYP

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Belmont Global Advisors's SGYP Position: Q3 2016 in Review

Belmont Global Advisors reduced its Synergy Pharmaceuticals, Inc Common Stock (SGYP) stake by 30% in Q3 2016, selling an estimated $538K and leaving 270,000 shares worth $1.49M. The position accounts for 1.41% of the portfolio, ranked #11.

Belmont Global Advisors first reported a position in SGYP in Q4 2013 and has held it in 11 quarters since. 149 funds tracked by Wall St. Rank hold SGYP as of Q3 2016.

Belmont Global Advisors held 270,000 shares of Synergy Pharmaceuticals, Inc Common Stock worth $1.49M as of Q3 2016.
Belmont Global Advisors sold 115,000 Synergy Pharmaceuticals, Inc Common Stock shares in Q3 2016, an estimated $538K.
Synergy Pharmaceuticals, Inc Common Stock made up 1.41% of Belmont Global Advisors's portfolio in Q3 2016, its #11 holding.
Belmont Global Advisors first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q4 2013 and has held it in 11 quarters since.
149 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q3 2016.

Based on Belmont Global Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.